First Mining Gold Corp. reported its Q3 2026 financial results highlighting a successful $58 million capital raise and inclusion in the GDXJ index, boosting liquidity and visibility. The company secured federal environmental approval for its Springpole Gold Project and signed agreements with indigenous communities, paving the way for provincial approval and construction decisions. Exploration at the Duparquet Gold Project showed promising results, with a resource update expected in Q1 2027. With $81 million in cash and marketable securities, First Mining is well-funded to advance its projects toward production.
First Mining's Q3 2026 financial results and project updates provide context for readers following mining developments. For readers following Basic Materials stocks on Pluang, here is the market snapshot as of Nov 11, 2026 15:51 WIB: out of 83 priced US stocks, 63 rose and 15 fell. Notable movers include IAUX at USD 1.44 with a 3.60% increase and a typical hold time of 9 days, CDE at USD 15.78 up 3.20% with 100% buy order activity, and AG at USD 15.41 rising 3.15% with a 7-day typical hold time and 100% buy orders.
NRx Pharmaceuticals has begun selling a new preservative-free ketamine made in the U.S., addressing a shortage that has persisted since 2018. This ketamine uses innovative blow-fill-seal technology, eliminating the preservative benzethonium chloride,...
FLSmidth & Co. A/S announced its financial calendar for 2027, including key dates for the annual report, interim financial reports, and the annual general meeting. The company emphasizes its commitment to sustainability with its MissionZero goal to a...
Dimensional Fund Advisors Ltd. has filed a Form 8.3 disclosure revealing it holds a 1.27% stake in Prologis Inc, totaling 12,054,886 shares as of November 10, 2026. This disclosure is part of regulatory requirements under the Takeover Code, indicatin...
Dimensional Fund Advisors Ltd. has filed a disclosure showing it holds a 1.61% stake in DCC Energy plc's ordinary shares as of November 10, 2026. The firm sold 42,998 shares recently at a price of £64.5585 each. This disclosure is part of regulatory ...
Novo Nordisk has committed $200 million to the World Diabetes Foundation for 2027–2036 to enhance diabetes prevention and care in low- and middle-income countries. This funding aims to improve equitable access to diabetes services in underserved comm...
